Forest Labs Defeats Icahn In Proxy Fight
The New York-based biopharmaceutical company said that shareholders had elected its entire slate of 10 directors at the company's annual meeting, rejecting Icahn's bid to place four members on the board.
Forest Chairman and CEO Howard Solomon praised the company's employees and touted the company's growth in a statement celebrating the win.
“We would also like...
To view the full article, register now.